Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats

European Journal of Pharmacology

Volumn 481, Issue 2-3, 2003, Pages 293-299

  De Cáceres, Inmaculada Ibáñez ^a   Priego, Teresa ^a   Martín, Ana Isabel ^b   Granado, Miriam ^a   López Calderón, Asunción ^a   Villanúa, Maria Angeles ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Aminoguanidine; Arthritis, adjuvant induced; IGFBP 3 (insulin like growth factor binding protein 3); IGFBP 3 mRNA; IGFBP 3 proteolysis; iNOS nitric oxide (NO) synthase, inducible

Indexed keywords

AMINOGUANIDINE; FREUND ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; GENE EXPRESSION; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT;

EID: 18344403950     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.038     Document Type: Article

References (35)

1. Albiston A.L., Herington A.C. Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochem. Biophys. Res. Commun. 166:1990;892-897.
2. Blantz R.C., Munger K. Role of nitric oxide in inflammatory conditions. Nephron. 90:2002;373-378.
3. Cannon G.W., Openshaw S.J., Hibbs J.B. Jr., Hoidal J.R., Huecksteadt T.P., Griffiths M.M. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum. 39:1996;1677-1684.
4. Chade A.R., Rodríguez-Porcel M., Grande J.P., Krier J.D., Lerman A., Romero J.C., Napoli C., Lerman L.O. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation. 106:2002;1165-1171.
5. Dijoseph J.F., Walter T.L., Hartman D.A., Carlson R.P. Kidney dysfunction in the arthritic rat. Int. J. Immunopharmacol. 15:1993;933-941.
6. Farrell A.J., Blake D.R., Palmer R.M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1992;1219-1222.
7. Feld S., Hirschberg R. Growth hormone, the insulin-like growth factor system, and the kidney. Endocr. Rev. 17:1996;423-480.
8. Fernihough J.K., Billingham M.E., Cwyfan-Hughes S., Holly J.M. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum. 39:1996;1556-1565.
9. Gad M.Z., Khattab M. Modulation of nitric oxide synthesis in inflammation. Relationship to oxygen-derived free radicals and prostaglandin synthesis. Arzneim.-Forsch. 50:2000;449-455.
10. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
11. Hernández-Pando R., Schon T., Orozco E.H., Serafin J., Estrada-Garcia I. Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis. Exp. Toxicol. Pathol. 53:2001;257-265.
12. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:1986;138-143.
13. Ibáñez de Cáceres I., Villanúa M.A., Soto L., Martín A.I., López-Calderón A. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. J. Endocrinol. 165:2000;537-544.
14. Ibánez de Cáceres I., Holly J.M., Priego T., Martín A.I., López-Calderón A., Villanúa M.A. Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity. J. Endocrinol. 173:2002;357-364.
15. Ibánez de Cáceres I., Priego T., Martín A.I., López-Calderón A., Villanúa M.A. GH administration and renal IGF-I system in arthritic rats. Life Sci. 71:2002;139-151.
16. Iñiguez G., Villavicencio A., Gabler F., Palomino A., Vega M. Effect of nitric oxide on the expression of insulin-like growth factors and the insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Reproduction. 122:2001;865-873.
17. Kone B.C., Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 272:1997;F561-F578.
18. Landau D., Chin E., Bondy C., Domene H., Roberts C.T. Jr., Gronbaek H., Flyvbjerg A., Le Roith D. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology. 136:1995;1835-1842.
19. Lang C.H., Nystrom G., Frost R.A. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha. Growth Horm. IGF Res. 11:2001;250-260.
20. López-Calderón A., Soto L., Martín A.I. Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. Life Sci. 65:1999;2049-2060.
21. López-Franco O., Suzuki Y., Sanjuan G., Blanco J., Hernández-Vargas P., Yo Y., Kopp J., Egido J., Gómez-Guerrero C. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am. J. Pathol. 161:2002;1497-1505.
22. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 5:2001;62-71.
23. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
24. Neidel J. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 19:2001;81-84.
25. Neidhart M., Fluckiger E.W. Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology. 177:1992;449-455.
26. Olney R.C., Wilson D.M., Mohtai M., Fielder P.J., Smith R.L. Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J. Endocrinol. 146:1995;279-286.
27. Roubenoff R., Freeman L.M., Smith D.E., Abad L.W., Dinarello C., Kehayias J.J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40:1997;534-539.
28. Sakurai H., Kohsaka H., Liu M.F., Higashiyama H., Hirata Y., Kanno K., Saito I., Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96:1995;2357-2363.
29. Selgas L., Arce A., Esquifino A.I., Cardinali D.P. Twenty-four-hour rhythms of serum ACTH, prolactin, growth hormone, and thyroid-stimulating hormone, and of median-eminence norepinephrine, dopamine, and serotonin, in rats injected with Freund's adjuvant. Chronobiol. Int. 14:1997;253-265.
30. Skamarauskas J.T., McKay A.G., Hunt J.V. Aminoguanidine and its pro-oxidant effects on an experimental model of protein glycation. Free Radic. Biol. Med. 21:1996;801-812.
31. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., Evans C.H. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. Rheumatol. 22:1995;1922-1928.
32. Tanaka H., Ueta Y., Yamashita U., Kannan H., Yamashita H. Biphasic changes in behavioral, endocrine, and sympathetic systems in adjuvant arthritis in Lewis rats. Brain Res. Bull. 39:1996;33-37.
33. Tanaka S., Matsui T., Murakami T., Ishizuka T., Sugiura M., Kawashima K., Sugita T. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. Int. J. Immunopharmacol. 20:1998;71-84.
34. Whellams E.J., Maile L.A., Fernihough J.K., Billingham M.E., Holly J.M. Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J. Endocrinol. 165:2000;545-556.
35. Yu P.H., Zuo D.M. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia. 40:1997;1243-1250.